Aspects of the present disclosure generally relate to positioning devices, methods, and procedures. In particular, aspects relate to using wave energy to position a medical device in a body.
Lung cancer is among the leading causes of cancer deaths worldwide, in part, because most new cases are not presented until later stages of development (e.g., at Stage III or IV). Screening for lung cancer reduces mortality by allowing a greater percentage of new cases to be presented at early stages (e.g., at Stage I or II) where the cancerous tissue can be more easily removed. Many screening procedures comprise, for example, identifying tissues that are suspected to be cancerous (e.g., a lung nodule >8 mm), and performing a lung biopsy on the identified tissue to confirm the presence and/or staging of cancer. In many cases, the lung biopsy is performed by placing a biopsy needle into the lung, and using a series of X-rays to position the biopsy needle at the identified tissue.
There are many problems with known procedures. For example, multiple X-rays may be required to position the biopsy needle, exposing both the patient and the physician to high amounts of radiation. This problem is of particular concern to physicians, and their technicians, who may perform more than one lung biopsy per day, and potentially hundreds per year. Moreover, because each X-ray captures a still image, and multiple X-rays are required to locate the biopsy needle in three dimensions, the physician cannot position the biopsy needle in real-time. Numerous starts and stops are thus required to position the needle, increasing operating times and the potential of damaging non-targeted tissues.
Aspects of the positioning devices, methods, and systems disclosed herein may solve one or more these problems and/or address other missing aspects of the prior art.
Aspects of the present disclosure relate to positioning devices, methods, and systems. Numerous aspects are now described.
One aspect of this disclosure is a positioning system. An exemplary system may comprise: a tube including a distal end with a tissue penetrating feature and one or more lumens extending through the tube; a shaft positioned in a first lumen of the one or more lumens; a transducer coupled to the shaft, the transducer being configured to generate a wave energy in response to a first signal, receive a reflected portion of the wave energy, and generate a second signal in response to the reflected portion of the wave energy; and one or more processors in communication with the transducer, the one or more processors being configured to generate the first signal, receive the second signal, and output indicia of the body in response to the second signal. In this system, a wave energy impedance of the tube may be similar to a wave energy impedance of the shaft, and the indicia may include a location of a targeted tissue in the body.
According to this aspect, the shaft may be movably positioned in the tube. A distal end of the shaft may include a tissue penetrating feature. The transducer may be mounted on an exterior surface of the shaft, or within an interior of the shaft. In some aspects, the transducer may include, for example, a cylindrical body extending along a central longitudinal axis, a proximal end opposite of a distal end along the central longitudinal axis, an array of side-looking transducers on the cylindrical body, an array of forward-looking transducers on the distal end, and an array of rearward-looking transducers on the proximal end. The array of forward-looking transducers may be movably mounted to the distal end of the cylindrical body. For example, the array of forward-looking transducers may be rotatable about the central longitudinal axis of the cylindrical body, as may any other array described herein. A lumen may extend through the shaft and the transducer. The array of side-looking transducers may be configured to generate a first wave energy, the array of forward-looking transducers may be configured to generate a second wave energy, and the second wave energy may be more focused than the first wave energy. In some aspects, the wave energy may be acoustic energy. For example, the transducer may include at least one piezoelectric ultrasound transducer, and the first and second signals may be electrical signals.
In other aspects, the indicia may include a graphical representation of the body. The one or more processors may be configured to determine, for example, a condition of the targeted tissue from the indicia. In still other aspects, the or more lumens may include a second lumen, and the system may comprise an elongated tool positioned in the second lumen. For example, the elongated tool may be movably positioned in the second lumen and include a working end composed of a shape-memory material that assumes a pre-determined shape when extended distally out of the second lumen.
Another aspect of this disclosure is a positioning method. An exemplary method may comprise: moving a distal end of a tube into a body passageway, the tube including a lumen extending therethrough and a shaft positioned in the lumen, the shaft having a transducer; sending a first signal to the transducer; passing, with the transducer, in response to the first signal, a wave energy into the body passageway through the tube and the shaft; receiving, with the transducer, a reflected portion of the wave energy; generating, with the transducer, a second signal in response to the reflected portion of the wave energy; and determining, with a processor, an indicia of the body passageway in response to the second signal; identifying, with the indicia, a targeted issue in the body passageway. In some aspects, the method may comprise positioning the distal end of the tube at the targeted tissue in response to the indicia; and removing a portion of the targeted tissue with the distal end of the tube.
According to this aspect, the indicia may include a graphical representation of the body, and the method may comprise determining a location of the targeted tissue with the graphical representation. The method may comprise determining a size of the targeted tissue with the indicia. For example, the wave energy may be acoustic energy, and the method may comprise determining, with the processor, a condition of the targeted tissue based on the reflected portion of the acoustic energy. In other aspects, the indicia may include a boundary of the targeted tissue, and the method may comprise determining, with the processor, whether the distal end of the tube has penetrated the boundary.
Yet another aspect of this disclosure is another positioning method. This method may comprise: moving a distal end of a tube in a lung, the tube including a lumen extending therethrough and a shaft positioned in the lumen, the shaft having a transducer mounted therein; sending and receiving, with the transducer, a wave energy through the tube and the shaft; generating, with a processor, using a reflected portion of the wave energy, indicia of the lung; locating, with the indicia, a lung nodule in the lung; guiding, with the indicia, the distal end of the tube into the lung nodule; and removing a portion of the nodule with the distal end of the tube.
According to this aspect, the method may comprise guiding, with the indicia, a distal end of the shaft towards the lung nodule. For example, the indicia may include a graphical representation of the lung (or a portion of the lung), and the method may comprise identifying, with one or more processors, a location of the lung nodule on the graphical representation. The method may comprise determining, from the indicia, a distance between the distal end of the tube and a proximal surface of the lung nodule. The distal end of the shaft may include a tissue penetrating portion, and the method may comprise: moving the tissue penetrating portion of the shaft into the lung nodule; and determining whether the nodule is solid-filled based upon the reflected portion of wave energy. In some aspects, the distal end of the tube may include a tissue penetrating portion, and the method may comprise: determining whether the density of the lung nodule exceeds a pre-determined maximum density; and moving the tissue penetrating portion of the tube into the nodule if the pre-determined maximum density is exceeded. In still other aspects, the shaft may include an echogenic indicator, and the method may comprise determining a location of the echogenic indicator with the indicia.
For example, the shaft may include a central longitudinal axis, the echogenic indicator may be offset from the central longitudinal axis, and the method may comprise determining a rotational position of the shaft with the indicia based on the location of the indicator relative to the central longitudinal axis.
Aspects of a positioning device are also disclosed with reference the methods and systems described above. Numerous exemplary devices, methods, and systems are now described in detail below, each including aspects relating to the use of wave energy as a means for positioning a medical device in a body (e.g., in a lung) to identify and confirm the location of a material in the body (e.g., a tumor in the lung), the material having an impedance distinguishable from healthy tissue of the body (e.g., healthy lung tissue).
It may be understood that both the foregoing summary and the following detailed descriptions are exemplary and explanatory only, neither being restrictive of the inventions claimed below.
The accompanying drawings are incorporated in and constitute a part of this specification. These drawings illustrate aspects of the present disclosure that, together with the written descriptions, serve to explain the principles of this disclosure.
Aspects of the present disclosure are now described with reference to exemplary positioning devices, methods, and systems. Some aspects are described with reference to a medical procedure (e.g., a lung biopsy), wherein a sensor (e.g., a transducer) is positioned in a body (e.g., in a lung) to identity a targeted tissue in the body (e.g., a solid-filled lung nodule), and guide a needle (e.g., a biopsy needle) toward the targeted tissue. Any reference to a particular procedure, such as a lung biopsy; a particular sensor, such as a transducer; a particular body, such as a lung; or a particular instrument, such as a biopsy needle, is provided for convenience and not intended to limit this disclosure unless claimed. Accordingly, the concepts disclosed herein may be used with any analogous device, method, or system—medical or otherwise.
The directional terms “proximal” and “distal,” and their respective initials “P” and “D,” are used to describe relative components and features of the present disclosure. Proximal refers to a position closer to the exterior of the body or a user, whereas distal refers to a position closer to the interior of the body or further away from the user. Appending the initials P or D to an element number signifies the element's proximal or distal location. Unless claimed, these directional terms and initials are provided for convenience and not intended to limit the present disclosure to a particular direction or orientation. As used herein, the terms “comprises,” “comprising,” or like variation, are intended to cover a non-exclusive inclusion, such that a device or method that comprises a list of elements does not include only those elements, but may include other elements not expressly listed or inherent thereto. Unless stated otherwise, the term “exemplary” is used in the sense of “example” rather than “ideal.”
The relative terms “echogenic” and “anechoic” are used to describe characteristics of certain “materials” in the present disclosure. The term materials may include any organic or non-organic material, including body fluids and tissues. The term echogenic may be attributed to materials with a higher resistance or impedance to a wave energy (also referred to as wave energy impedance), meaning that at least a portion of the wave energy will be reflected off such materials. For example, an echogenic material may produce internal echoes, such as reflections of ultrasound waves. Air and metal, for example, may be considered echogenic materials in some ultrasound applications. The term echogenic may also be used to describe a relative difference between two materials. For example, an internal echo may be produced by a first material (e.g., air) and a second material (e.g., metal) in response to wave energy. If a magnitude of each echo is different, then those materials may be described as echogenic with respect to one another. Conversely, the term anechoic may be attributed to materials with a lower resistance or impedance to wave energy (or low wave energy impedance), meaning that at least a portion of the wave energy will pass through such materials. Healthy lung tissue and certain polymers, for example, may be considered anechoic materials in some ultrasound applications. The term anechoic may also be used to described a relative similarity between two materials. For example, if the magnitude of an echo produced by a first material (e.g., lung tissue) is equal to a magnitude produced by a second material (e.g., a polymer), then those materials may be described as being anechoic with respect to one another. Unless claimed as such, neither of these relative terms, echogenic or anechoic, is intended to be absolute.
The term □indicia□ is used in this disclosure to mean any real-time indication of a particular characteristic of a body. One form of indicia is a data model that is generated in response to one or more electrical signals and usable to determine characteristics of the body, such as the location and/or size of a cavity in the body, the location of its boundaries, and the location of a targeted tissue in the cavity. The data model may, for example, be created by an operator or processor, and used by the operator as a real-time guide to position a medical device in the body. Another form of indicia is a two- or three-dimensional graphical representation of the body that is generated in response to the one or more electrical signals, or with the data model. The graphical representation may also be used by the operator as a real-time guide to position a medical device in the body.
One aspect of the present disclosure is an exemplary device 10 configured to generate indicia of a body. As shown in
Tube 20 of
Shaft 40 is an elongated element that extends in a direction parallel to axis X-X. In
Transducer 50 of
In one aspect, the wave energy is acoustic energy, and transducer 50 includes at least one array (e.g., a two- or three-dimensional array) of piezoelectric ultrasound transducers configured to generate an ultrasonic wave (e.g., a pulse or train of pulses) in response to the first electrical signal, and generate the second electrical signal in response to a reflected portion of the ultrasonic wave. A frequency of the ultrasound wave may be selected based upon a desired combination of accuracy and depth. For example, if greater accuracy is desired, then a higher frequency may be used; whereas, if greater depth is required, then a lower frequency may be used. In some aspects, the frequency may be approximately 5 MHz or lower; between approximately 5 and 20 MHz; between approximately 10 and 30 MHz; at least 40 MHz; approximately between 20 and 60 MHz; or approximately 60 MHz or lower. Any suitable intermediate and/or comparable frequency values and/or ranges may be used. In some aspects, a plurality of transducers 50 may used, wherein, responsive to one or more signals, a first portion is configured to optimize accuracy and a second portion is configured to optimize depth.
An exemplary transducer 50 is illustrated in
Another aspect of the present disclosure is now described with reference to a system 100 including a device 110 that, like device 10, may be used to generate indicia of a body, depicted as a lung 1 in
Tube 120 of
Shaft 140 is movably positioned in lumen 122. A section view of tube 120 and shaft 140 is shown in
Tube 120 and shaft 140 may include one or more echogenic markers. For example, as shown in
An exemplary transducer 150 is depicted in
The wave energy impedance of tube 120 and shaft 140 may determine the location of transducer 150. For example, if tube 120 and shaft 140 are made of similar anechoic materials (e.g., PEEK), then the distal end portion 121 of tube 120 may be used to pierce a body tissue, meaning that transducer 150 may be located anywhere on or within shaft 140 and/or tube 120 because a majority of the wave energy will pass through each element. Alternatively, if distal end portion 121 of tube 120 is made of an echogenic material (e.g., stainless steel), then transducer 150 should be located on a portion of shaft 140 that is extendable from tube 120 to expose transducer 150, else a majority of the wave energy will not escape tube 120.
In system 100, the capabilities of transducer 150 may be modified by shaft lumen 146 to permit addition of new arrays, sensors, tools, and the like. In some aspects, at least forward-looking array 153 of
A sensor may be provided in lumen 146. For example, a sensor may be placed on an interior surface of lumen 146 to track the location of shaft 140 (or marker 145) relative to tube 120 (or marker 125) as it passes by said sensor along axis X-X. Other elongated elements, such as a guide wire, an optical cable, or an elongated tool, may be delivered to lung 1 through shaft lumen 146.
A portion of transducer 150 may be movably mounted in lumen 146. For example, as shown in
Processor 160 is in communication with transducer 150 and may include one or more processors that are local (e.g., an element of device 10) and/or remote (e.g., an internet connected server) thereto. Any wired or wireless means may be used to facilitate communication between processor 160 and transducer 150. In
Processor 160 outputs indicia of lung 1 in response to the second electrical signals. For example, as illustrated in
Using other comparative methods, processor 160 may likewise be used to determine, for example, the size of a particular solid-filled nodule 3, the location of a plurality of nodules 3 in lung 1, a condition (e.g., the density) of a particular nodule 3, and the like. Still other capabilities may be realized with system 100. For example, because each of tube 120, shaft 140, and the fluid have as similar wave energy impedance, transducer 150 may be □always-on□ because the indicia output by processor 160 is not affected by the position of shaft 140 relative to tube 120. In this regard, there is no need to position the distal end 140D of shaft 140 at a point distal of the distal end 120D of tube 120, as shown in
Still other aspects of the present disclosure are described with reference to a device 210. As shown in
For tube 220, first lumen 222A extends through tube 220 along first axis X1-X1, while second lumen 222B extends through tube 220 along a second longitudinal axis X2-X2 that is parallel to first longitudinal axis X1-X1. A section view of tube 220 is provided in
Elongated tool 280 is movable in second lumen 222B relative to axis X2-X2 in a translational and rotational manner. For example, the distal end 220D of tube 220 may be placed adjacent tissue (e.g., tissue 3 of
All or at least portions of elongated tool 280 may have a wave energy impedance similar to that of tube 220, shaft 240, and/or the fluid, allowing the wave energy to pass through each of those elements. If composed of a metal, then working end 284 may have a different wave energy impedance so that the position of tip 286 may be determined from the indicia. For example, in a graphical representation generated from the indicia, using the wave energy, working end 284 and tip 286 may be distinguishable from the body, a targeted tissue in the body, and the remainder of device 210, each of which may have a wave energy impedance different from that of tip 286.
Various echogenic markers may be provided on tube 220, shaft 240, and/or tool 280 so that the relative locations of these elements may be determined from the indicia.
The operator may also use the indicia to determine a distance between distal end 220D of tube 220 and portions of tool 280. As shown in
Other aspects of the present disclosure include exemplary methods of using devices 10, 110, and 210. An exemplary method 300 is shown in
Preparing device 10 (310) may include any methods necessary to generate the indicia, such as sterilization, providing power, enabling communications, and the like. Moving distal end 20D (320) may likewise include any methods necessary to access the body, including invasive and non-invasive surgical methods. and/or methods of imaging guidance. Sending the first electrical signal to transducer 50 (330) may be performed by a processor, such as processor 160 of
The wave energy may be sent and received through portions of tube 20 and shaft 40. To enhance the indicia, each of tube 20 and shaft 40 may have a similar wave energy impedance so that the wave energy may be passed through tube 20 and shaft 40 without distortion. For example, moving distal end 20D of tube 20 into a body (320) may further comprise moving shaft 40 relative to tube 20 until distal end 20D of tube 20 is distal of distal end 40D of shaft 40. Because tube 20 and shaft 40 share a common wave energy impedance, the quality of any indicia generated from the second electrical signal may be similar no matter the position of distal ends 20D and 40D.
Generating a second electrical signal in response to the reflected portion of the wave energy (360) may be performed by transducer 50. If transducer 50 includes arrays 53, 54, and 55, as described above, and each array 53, 54, and 55 generates a plurality of second electrical signals, then generating the second electrical signal (360) may further comprise combining the plurality of second signals. Determining an indicia of the body with the first and second signals (370) may be performed by a processor that, as described above, analyzes the first and second signals, performs various calculations therewith, and outputs the indicia. These determinations (370) may further include determining a magnitude and/or timing of each second electrical signal, comparing the magnitudes and/or timing of each second signal, and identifying a targeted tissue in the body based upon such comparisons. Similar comparative methods be used to determine, for example, the size of the targeted tissue, the location of a plurality of such tissues, a condition of said tissues (e.g., density or porosity), and the like. Aspects of the wave energy may be varied to support these determinations. For example, method 300 may further include identifying the boundaries of the body with a first wave energy generated by transducer 50, and identifying a targeted tissue in the body with a second wave energy generated by transducer 50.
Although not required, method 300 of
Aspects of method 300 may be modified for use with system 100. For example, each of tube 120 and shaft 140 may have a similar wave energy impedance to the fluid so that the wave energy may be passed through tube 120, shaft 140, and/or the fluid without distortion. In other aspects of method 300, the first electrical signal may be sent by processor 160 at 330, the second electrical signal may be received at processor 160 at 360, and processor 160 may be used to determine the indicia at 370. Because of processor 160, any number of additional determination steps may be included in method 300, including those described herein. Echogenic markers 125 and 145 of system 100 (
Still other aspects of method 300 may be modified for use with device 220. For example, positioning the distal end 220D of tube 220 (380) may further include positioning the distal end 280D of tool 280 at the targeted tissue. The indicia determined at 370 of method 300 may be used to guide working end 284 of tool 280. For example, method 300 may further comprise determining a distance between tip 286 and a targeted tissue, and moving tube 220 and/or tool 280 to ensure that tip 286 will be moved toward the targeted tissue when working end 284 forms its pre-determined shape. Additional echogenic markers may be placed on tube 220 and/or tool 280 to facilitate such movements.
The various aspects of method 300 may be performed in any order. Moreover, in some aspects, method 300 may comprise less than all of the described aspects without departing from this disclosure. For example, the aspects of method 300 at 310 and/or 380 of
While principles of the present disclosure are disclosed herein with reference to illustrative aspects for particular applications, the disclosure is not limited thereto. Those having ordinary skill in the art and access to the teachings provided herein will recognize additional modifications, applications, aspects, and substitution of equivalents all fall in the scope of the aspects disclosed herein. Accordingly, the present disclosure is not to be considered as limited by the foregoing description.
This application is a continuation of U.S. Non-Provisional application Ser. No. 15/665,057, filed on Jul. 31, 2017, which claims the benefit of U.S. Provisional Application No. 62/370,455, filed Aug. 3, 2016, the disclosure of which is incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
4750488 | Wuchinich et al. | Jun 1988 | A |
5398690 | Batten et al. | Mar 1995 | A |
5487387 | Trahey et al. | Jan 1996 | A |
6059731 | Seward et al. | May 2000 | A |
6157852 | Selmon et al. | Dec 2000 | A |
6306097 | Park et al. | Oct 2001 | B1 |
6494841 | Thomas et al. | Dec 2002 | B1 |
6936048 | Hurst | Aug 2005 | B2 |
9289185 | Mung et al. | Mar 2016 | B2 |
20020077627 | Johnson et al. | Jun 2002 | A1 |
20040252870 | Reeves et al. | Dec 2004 | A1 |
20050113693 | Smith et al. | May 2005 | A1 |
20060253107 | Hashimshony et al. | Nov 2006 | A1 |
20080114309 | Zuckerman | May 2008 | A1 |
20090030312 | Hadjicostis | Jan 2009 | A1 |
20100047210 | Johnson et al. | Feb 2010 | A1 |
20110066073 | Kuiper et al. | Mar 2011 | A1 |
20110098572 | Chen et al. | Apr 2011 | A1 |
20140171788 | Stigall | Jun 2014 | A1 |
20140257102 | Hossack | Sep 2014 | A1 |
20150094595 | Havel et al. | Apr 2015 | A1 |
20160242733 | Lenox et al. | Aug 2016 | A1 |
20210118130 | Zhang et al. | Apr 2021 | A1 |
Number | Date | Country |
---|---|---|
2001104315 | Apr 2001 | JP |
2016025389 | Feb 2016 | WO |
Number | Date | Country | |
---|---|---|---|
20230255609 A1 | Aug 2023 | US |
Number | Date | Country | |
---|---|---|---|
62370455 | Aug 2016 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15665057 | Jul 2017 | US |
Child | 18138937 | US |